Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G EVANS

Showing results (361-370 of 392) with videos related to

Pageof 40
Sort By:
Journal of Internal Medicine|February 2, 2012
Prevention of breast cancer in the context of a national breast screening programmeA Howell, S Astley, J Warwick, et al.
Neurogenetics|January 25, 2016
A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screeningE H Gerkes, J M Fock, W F A den Dunnen, et al.
Oncogene|July 29, 1998
Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like familyJ M Varley, P Chapman, G McGown, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|December 14, 2016
Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapiesM Ruggieri, A D Praticò, A Serra, et al.
Journal of Medical Genetics|April 17, 2008
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinicsA C Antoniou, R Hardy, L Walker, et al.
Familial Cancer|April 16, 2021
Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG)L Guerrini-Rousseau, M J Smith, C P Kratz, et al.
Clinical Genetics|November 23, 2012
The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome familiesM Pinheiro, C Pinto, A Peixoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2022
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice GuidelineC Sessa, J Balmaña, S L Bober, et al.
Familial Cancer|February 3, 2021
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working GroupM C Frühwald, K Nemes, H Boztug, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2025
Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendationsC Turnbull, M I Achatz, J Balmaña, et al.
Pageof 40

Showing results (361-370 of 392) with videos related to

Sort By:
Pageof 40
Journal of Internal Medicine|February 2, 2012
Prevention of breast cancer in the context of a national breast screening programmeA Howell, S Astley, J Warwick, et al.
Neurogenetics|January 25, 2016
A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screeningE H Gerkes, J M Fock, W F A den Dunnen, et al.
Oncogene|July 29, 1998
Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like familyJ M Varley, P Chapman, G McGown, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|December 14, 2016
Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapiesM Ruggieri, A D Praticò, A Serra, et al.
Journal of Medical Genetics|April 17, 2008
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinicsA C Antoniou, R Hardy, L Walker, et al.
Familial Cancer|April 16, 2021
Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG)L Guerrini-Rousseau, M J Smith, C P Kratz, et al.
Clinical Genetics|November 23, 2012
The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome familiesM Pinheiro, C Pinto, A Peixoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2022
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice GuidelineC Sessa, J Balmaña, S L Bober, et al.
Familial Cancer|February 3, 2021
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working GroupM C Frühwald, K Nemes, H Boztug, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2025
Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendationsC Turnbull, M I Achatz, J Balmaña, et al.
Pageof 40